Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Tag
  • N-6xHis
    (3)
  • C-His
    (2)
  • C-His-Avi
    (2)
  • C-hFc
    (1)
  • N-His
    (1)
TargetMol | Tags By Expression System
  • HEK293 Cells
    (5)
  • E. coli
    (2)
  • P. pastoris (Yeast)
    (2)
TargetMol | Tags By Species
  • Human
    (6)
  • Mouse
    (2)
  • H1N1
    (1)
TargetMol | Tags By SPR-compatible Buffer
  • Ready-to-use
    (5)
  • Buffer exchange required
    (2)
  • Buffer-exchangeable
    (2)
Filter
Search Result
Results for "

interferon-r

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    1
    TargetMol | Inhibitors_Agonists
  • Recombinant Protein
    9
    TargetMol | Recombinant_Protein
  • Antibody Products
    12
    TargetMol | Antibody_Products
TargetMolTargetMolCompare
IFN gamma Protein, Human, Recombinant (His & Avi)
γ, Interferon-γ, Interferon-gamma, interferon, IFNγ, IFN γ IFNG, IFN γ, IFN gamma, IFI, IFG, gamma
TMPK-00047
Expression system: HEK293 Cells
Length: 24-161, Full Length of Mature Protein
Activity: ELISA
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
IFN gamma Protein, Human, Recombinant (His & Avi), Biotinylated
γ, Interferon-γ, Interferon-gamma, interferon, IFNγ, IFN γ IFNG, IFN γ, IFN gamma, IFI, IFG, gamma
TMPK-00048
Expression system: HEK293 Cells
Length: 24-161, Full Length of Mature Protein
Activity: ELISA
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
IFNAR2 Protein, Mouse, Recombinant (His)
Type I interferon receptor 2, Interferon alpha beta receptor 2, IFN-R-2, Ifnar2, IFN-alpha beta receptor 2
TMPH-02732
Expression system: P. pastoris (Yeast)
Length: 22-242, Extracellular Domain
Activity: Not Tested
  • Inquiry Price
20 days
Size
QTY
Buffer-exchangeable
TargetMolTargetMolCompare
IFNAR2 Protein, Human, Recombinant (hFc)
interferon (α, β and ω) receptor 2, interferon (α, β and Ω) receptor 2, interferon (alpha, beta and omega) receptor 2, IFN-α-REC, IFN-R, IFNARB, IFN-alpha-REC, IFNABR
TMPY-01640
Expression system: HEK293 Cells
Length: 1-243, Extracellular Domain
Activity: ELISA、Cells
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
IFNAR2 Protein, Human, Recombinant (His)
interferon (α, β and ω) receptor 2, interferon (α, β and Ω) receptor 2, interferon (alpha, beta and omega) receptor 2, IFN-α-REC, IFN-R, IFNARB, IFN-alpha-REC, IFNABR
TMPY-01642
Expression system: HEK293 Cells
Length: 1-243, Extracellular Domain
Activity: Cell Activity
  • Inquiry Price
7-10 days
Size
QTY
SPR-compatible buffer
TargetMolTargetMolCompare
Influenza A H1N1 (A/Puerto Rico/8/34/Mount Sinai) Non-structural/NS1 Protein (His)
NS1 Protein
TMPY-02219
The NS1 Influenza protein is created by the internal protein-encoding, linear negative-sense, single-stranded RNA, NS gene segment and which also codes for the nuclear export protein or NEP, formerly referred to as the NS2 protein, which mediates the export of vRNPs. The non-structural (NS1) protein is found in Influenzavirus A, Influenzavirus B, and Influenzavirus C. The non-structural (NS1) protein of the highly pathogenic avian H5N1 viruses circulating in poultry and waterfowl in Southeast Asia is currently believed to be responsible for the enhanced virulence of the strain. The Non-structural (NS1) protein of influenza A virus is a non-essential virulence factor that has multiple accessory functions during viral infection. The major role ascribed to NS1 has been its inhibition of host immune responses, especially the limitation of both interferon (IFN) production and the antiviral effects of IFN-induced proteins, such as dsRNA-dependent protein kinase R (PKR) and 2'5'-oligoadenylate synthetase (OAS) RNase L. Non-structural (NS1) protein is a non-structural protein of the influenza A virus, which could only be expressed when cells are infected. The effect of NS1 protein on the host cell is still not clear. Not only could NS1 remarkably affect metabolism, but it could also slow down cell proliferation by blocking the cell cycle. Non-structural (NS1) protein may lead to the development of novel antiviral drugs, and the use of oncolytic influenza A viruses as potential anti-cancer agents.
  • Inquiry Price
7-10 days
Size
QTY